secwatch.observer — SEC 8-K summary
======================================

Issuer:     Third Harmonic Bio, Inc. (—)
CIK:        0001923840
Form:       8-K
Filed at:   2025-02-11T23:59:59+00:00
Accession:  0001193125-25-023995
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 2.05, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Third Harmonic Bio cuts workforce by 50%, expects $2.3M restructuring costs; cash runway extended
--------------------------------------------------------------------------------

- Reducing headcount by ~27 employees (50%) under restructuring plan; completion expected by Q2 2025.
- Estimated severance and exit costs of $2.3M, recorded primarily in Q1-Q2 2025.
- Preliminary, unaudited cash and equivalents of ~$285M as of Dec 31, 2024.
- Projected cash balance of $262M-$267M as of June 30, 2025 after THB335 Phase 2 readiness and restructuring costs.
- Company refocusing on THB335 Phase 2 readiness as strategic priority.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1923840/000119312525023995/0001193125-25-023995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1923840/000119312525023995/d867173d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-023995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer